BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3547731)

  • 1. [Role of systemic chemotherapy in the treatment of squamous cell carcinoma of the head and neck].
    Bruntsch U
    Sonderb Strahlenther Onkol; 1987; 81():92-8. PubMed ID: 3547731
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating novel agents into the curative treatment of head and neck cancer.
    Haddad R; Allen A; Wirth L; Tishler R; Posner M
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):157-9. PubMed ID: 16445367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cytostatic treatment of advanced squamous cell carcinoma of the head and neck].
    Berthelsen A; Nielsen ES; Rygård J
    Ugeskr Laeger; 1986 Aug; 148(33):2074-80. PubMed ID: 3750541
    [No Abstract]   [Full Text] [Related]  

  • 5. Second-line chemotherapy in head and neck cancer: what should we expect?
    Büntzel J; Micke O
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of unknown primary squamous cell carcinoma in the neck showing a high response with combined chemotherapy including nedaplatin, adriamycin and 5-fluorouracil].
    Yamashita S; Hirao M; Tsujinaka T; Sawamura T; Nakamori S; Mishima H; Fujitani K; Ikenaga M; Kashiwazaki M; Masuda N
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1149-51. PubMed ID: 16121918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of neoadjuvant chemotherapy for management of resectable head and neck cancer].
    Horiuchi M; Tamura Y; Miyake H
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):417-24. PubMed ID: 8129381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoradiotherapy in unresectable squamous cell head and neck cancer.
    Blot E; Staub E
    J Clin Oncol; 2003 Oct; 21(20):3887; author reply 3887-8. PubMed ID: 14551314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapy of head and neck cancer].
    Kohno N; Nakazawa E; Kusunoki M; Nishiya M
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):277-82. PubMed ID: 8712819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for head and neck cancer.
    Tannock IF
    J Otolaryngol; 1984 Apr; 13(2):99-104. PubMed ID: 6202878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenging integration of platinum compounds, taxanes, and molecular-targeted therapies in the multidisciplinary treatment of squamous cell carcinoma of the head and neck.
    Awada A; Ismael G
    Curr Opin Oncol; 2007 May; 19(3):177-9. PubMed ID: 17414633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy in the management of squamous cell cancer of the head and neck.
    Posner MR; Colevas AD
    Cancer J Sci Am; 1997; 3(2):73-5. PubMed ID: 9099455
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a new role for induction chemotherapy in the treatment of head and neck cancer?
    Forastiere AA
    J Natl Cancer Inst; 2004 Nov; 96(22):1647-9. PubMed ID: 15547172
    [No Abstract]   [Full Text] [Related]  

  • 15. Palliation in incurable head and neck cancers: chemotherapy?
    Pantvaidya GH; D'Cruz AK; Prabhash K
    J Clin Oncol; 2005 Nov; 23(31):8128-9; author reply 8129-30. PubMed ID: 16258117
    [No Abstract]   [Full Text] [Related]  

  • 16. Standard, and novel cytotoxic and molecular-targeted, therapies for HNSCC: an evidence-based review.
    Murdoch D
    Curr Opin Oncol; 2007 May; 19(3):216-21. PubMed ID: 17414639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative treatment of head and neck squamous cancer with cisplatin and hydroxyurea.
    Taylor SG; Showel J
    Cancer Treat Rep; 1984 Jun; 68(6):932-3. PubMed ID: 6203641
    [No Abstract]   [Full Text] [Related]  

  • 18. Paclitaxel, cisplatin, 5-fluorouracil and radiotherapy in the management of advanced squamous cell carcinoma of the head and neck: a phase II trial.
    Merlano M; Russi EG; Numico G; Colantonio I; Garrone O; Pelissero A; Granetto C; Gasco M; Di Costanzo G; Heouaine A; Vigna Taglianti R; Cipolat M
    Radiother Oncol; 2005 May; 75(2):193-6. PubMed ID: 16086909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
    J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding role of systemic therapy in head and neck cancer.
    Cohen EE; Lingen MW; Vokes EE
    J Clin Oncol; 2004 May; 22(9):1743-52. PubMed ID: 15117998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.